3,4-methylenedioxymethamphetamine (MDMA) interacts with therapeutic drugs on CYP3A by inhibition of pregnane X receptor (PXR) activation and catalytic enzyme inhibition.

I. Antolino-Lobo, J. Meulenbelt, S.M. Nijmeijer, R.F.M. Maas-Bakker, I. Meijerman, M. van den Berg, M.B.M. van Duursen

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of '3,4-methylenedioxymethamphetamine (MDMA) interacts with therapeutic drugs on CYP3A by inhibition of pregnane X receptor (PXR) activation and catalytic enzyme inhibition.'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science